Chemed Reports Strong Q3 2026 Outlook and Strategic Franchise Reacquisitions
Chemed (CHE) reported strong third-quarter 2026 results, projecting full-year adjusted earnings per share to meet or slightly exceed the top end of previous guidance. The company's dual-sector model is driving growth through strategic investments in its Roto-Rooter plumbing franchise and capacity expansion within VITAS Healthcare. To build long-term scale, Chemed invested $96 million in 2026 to reacquire Roto-Rooter territories in California and Texas. While these acquisitions may temporarily suppress EBITDA margins due to integration costs, management expects rapid top-line revenue expansion. Simultaneously, VITAS Healthcare saw a 9.4% increase in average daily patient census, supported by efficient staffing tools that mitigated labor shortages and wage pressures.

Tickers: $CHE
Topics: earnings guidance EBITDA margins franchise acquisition hospice care growth